Skip to main content
Premium Trial:

Request an Annual Quote

Dante Labs Acquires Cambridge Cancer Genomics

NEW YORK — Dante Labs said on Wednesday that it has acquired UK-based cancer informatics firm Cambridge Cancer Genomics, or CCG, for an undisclosed amount.

Additional terms of the deal were not disclosed.

According to New York City-based Dante Labs, the acquisition will bring together its CE-IVD-marked Immensa Genomics Interpretation Software, which enables the interpretation of whole-genome sequencing data in a clinical setting, with CCG's artificial intelligence-based OncOS precision oncology software.

About a year ago, Dante Labs and CCG began working together with Nonacus to build a high-throughput cancer sequencing and interpretation service for tumor profiling.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.